Details of the Drug

General Information of Drug (ID: DM6QZ5R)

Drug Name

REACT

Indication

Disease Entry	ICD 11	Status	REF
Chronic kidney disease	GB61	Phase 3	[1]
------------------------------------------------------------------------------------

Drug Type

Cell therapy

Cross-matching ID

References

1	ClinicalTrials.gov (NCT05099770) A Phase 3 Randomized Controlled Study of Renal Autologous Cell Therapy (REACT) in Subjects With Type 2 Diabetes and Chronic Kidney Disease (REGEN-006). U.S.National Institutes of Health.